Loading
Latest filing published 22 Nov 2023 for Annovis Bio, Inc., €11k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
All filings by Mark K. White on record concern Annovis Bio, Inc., in the capacity of board member. In total, 4 filings cover trades dated from 12 October 2021 to 20 November 2023.
No open-market sale appears; the market trades are 1 purchase worth €119k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants.
The newest entry dates from 22 November 2023: a share grant of €11k, in Annovis Bio, Inc. The most recent open-market purchase was published on 13 October 2021, 1,831 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations